← Leaderboards
Sharon S Evans
Roswell Park Cancer Institute Corp
$8,115,501
Attributed
$9,838,159
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $788.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,838,159 · 4
By mechanism
R01$9,582,102 · 3
R56$256,057 · 1
Top collaborators
- Scott I. Abrams5 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Scott I. Abrams$11,133,748
- Walter J Storkus$19,974,413
- Elizabeth Repasky$12,725,917
- Shipra Gandhi$788,190
Others in their field
Top investigators on “Chemokine”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Andrew D Luster · Massachusetts General Hospital$27,938,802
- Joan Weinberger Berman · Yeshiva University$24,229,643
- Larry Arthur$22,516,306
- Maurizio Fava · Massachusetts General Hospital$19,116,294
- Lionel B Ivashkiv · Hospital For Special Surgery$18,420,856
Research focus
ChemokineLymphocyteSiteLaboratoriesMediatingResponseBloodAdhesivesTraffickingImmuneInsightIntercellular Adhesion Molecule 1T-LymphocyteGeneticLeukocytesLymph NodesBaseLeadHomingMalignant NeoplasmsImmune ResponseAntibodiesCellsAdhesions
Grant awards (24)
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity$697,166
R01 · FY2025 · CA · contact PI
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity$662,308
R01 · FY2024 · CA · contact PI
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity$680,292
R01 · FY2023 · CA · contact PI
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity$694,227
R01 · FY2022 · CA · contact PI
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity$711,323
R01 · FY2021 · CA · contact PI
Inflammatory Control of Lymphocyte Trafficking$487,435
R01 · FY2014 · AI · contact PI
Inflammatory Control of Lymphocyte Trafficking$451,620
R01 · FY2013 · AI · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$300,266
R01 · FY2013 · CA · contact PI
Inflammatory Control of Lymphocyte Trafficking$473,663
R01 · FY2012 · AI · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$314,958
R01 · FY2012 · CA · contact PI
Inflammatory Control of Lymphocyte Trafficking$467,076
R01 · FY2011 · AI · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$310,612
R01 · FY2011 · CA · contact PI
Inflammatory Control of Lymphocyte Trafficking$465,332
R01 · FY2010 · AI · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$311,648
R01 · FY2010 · CA · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$311,648
R01 · FY2009 · CA · contact PI
Inflammatory Control of Lymphocyte Trafficking$256,057
R56 · FY2009 · AI · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$323,608
R01 · FY2007 · CA · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$328,543
R01 · FY2006 · CA · contact PI
Leukocyte-Endothelial Adhesion in Tumor Immunity$331,747
R01 · FY2005 · CA
Leukocyte-Endothelial Adhesion in Tumor Immunity$327,181
R01 · FY2004 · CA
Leukocyte-Endothelial Adhesion in Tumor Immunity$322,749
R01 · FY2003 · CA
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY$207,536
R01 · FY2002 · CA
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY$201,492
R01 · FY2001 · CA
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY$199,672
R01 · FY2000 · CA